PRESS RELEASE published on 06/04/2024 at 17:45, 5 months 16 days ago NUMBER OF SHARES AND VOTING RIGHTS (ARTICLE L.233-8-II OF COMMERCIAL LAW) AT 31 MAY 2024 Ateme shares (ISIN: FR0011992700 – Ticker: ATEME) are now listed on Euronext Paris, compartment C. Ateme is a global leader in video compression and delivery solutions, focusing on boosting viewership and subscription engagement Euronext Paris Global Leader Video Compression Ateme Shares Subscription Engagement
BRIEF published on 05/23/2024 at 11:05, 5 months 29 days ago Provision of preparatory documentation for the General Meeting of Shareholders of June 12, 2024 Shareholders Meeting General Assembly Documentation ATEME
BRIEF published on 04/29/2024 at 20:05, 6 months 21 days ago ATEME Announces Approval of 2023 Universal Registration Document by AMF AMF Corporate Governance Financial Reports Universal Registration Document ATEME
PRESS RELEASE published on 04/29/2024 at 20:00, 6 months 21 days ago PUBLICATION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT Ateme's 2023 registration document approved by AMF with financial reports, management and governance reports, and share repurchase program description. A global leader in video compression and delivery solutions AMF Financial Report ATEME Video Compression Delivery Solutions
BRIEF published on 04/25/2024 at 17:50, 6 months 25 days ago Slowdown at ATEME in the First Quarter of 2024 Media Technology Turnover Technology Partnerships ATEME NAB Show
PRESS RELEASE published on 04/25/2024 at 17:50, 6 months 25 days ago FIRST QUARTER 2024 REVENUES Ateme reports Q1 2024 revenues of €17.7 million, down 35% reflecting comparison basis in USA/Canada region. Financial objectives confirmed. Recent NAB Show confirms Ateme's growing reputation Financial Objectives ATEME NAB Show Q1 Revenues Reputation
Published on 11/21/2024 at 13:30, 32 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 32 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 2 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 26 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 46 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 4 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 42 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 17 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 17 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
